Serum-free media and the immunoregulatory properties of mesenchymal stem cells in vivo and in vitro

Cellular Physiology and Biochemistry

Volumn 33, Issue 3, 2014, Pages 569-580

  Wu, Mei ^a   Han, Zhi Bo ^b,c   Liu, Jun Feng ^c   Wang, You Wei ^c   Zhang, Jian Zhong ^c   Li, Chun Tuan ^a   Xin, Peng Liang ^a   Han, Zhong Chao ^b,c   Zhu, Xiong Peng ^a  

^a FUJIAN MEDICAL UNIVERSITY   (China)

^b PEKING UNION MEDICAL COLLEGE   (China)

^c TEDA   (China)

Author keywords

Immunomodulation; Mesenchymal stem cells; Serum free media; Umbilical cord

Indexed keywords

CYCLOOXYGENASE 2; GAMMA INTERFERON; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 6; MONOCROTALINE; PROSTAGLANDIN E2; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE; INDOLEAMINE 2,3 DIOXYGENASE; INDOLEAMINE 2,3-DIOXYGENASE 1, HUMAN; PTGS2 PROTEIN, HUMAN; SERUM-FREE MEDIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CULTURE MEDIUM; CYTOKINE PRODUCTION; FEMALE; HUMAN; HUMAN CELL; IMMUNOMODULATION; IMMUNOREGULATION; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE PROLIFERATION; MESENCHYMAL STEM CELL; NONHUMAN; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RAT; CELL PROLIFERATION; CYTOKINE RELEASE; HUMAN TISSUE; STEM CELL EXPANSION; ANIMAL; BOVINE; CYTOLOGY; DRUG EFFECTS; GENE EXPRESSION REGULATION; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; MESENCHYMAL STROMA CELL; PHARMACOLOGY; SERUM-FREE MEDIUM;

BOVINAE;

ANIMALS; APOPTOSIS; CATTLE; CD4-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; CULTURE MEDIA, SERUM-FREE; CYCLOOXYGENASE 2; CYTOKINES; DINOPROSTONE; GENE EXPRESSION REGULATION; HUMANS; IMMUNE TOLERANCE; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; MESENCHYMAL STROMAL CELLS;

EID: 84895687949     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000358635     Document Type: Article

References (42)

1. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach, Marini F, Krause D, Deans R, Keating A, Prockop Di, Horwitz E: Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006;84:315-317.
2. Friedenstein AJ, Petrakova KV, Kurolesova AI, Frolova GP: Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues. Transplantation 1968;62:230-247.
3. Hu Y, Liao L, Wang Q, Ma G, Jiang X, Zhao RC: Isolation and identification of mesenchymal stem cells from human fetal pancreas. J Lab Clin Med 2003;1415: 342-349.
4. Barry FP, Murphy JM. Mesenchymal stem cells: Clinical applications and biological characterization. Int J Biochem Cell Biol 2004;36:568-584.
5. in'tAnker PS, Noort WA, Scherjon SA, Kleijburg-van der Keur C, Kruisselbrink AB, van Bezooijen RL, Beekhuizen W, Willemze R, Kanhai HH, Fibbe WE: Mesenchymal stem cells in human second-trimester bone marrow, liver, lung, and spleen exhibit a similar immunophenotype but a heterogeneous multilineage differentiation potential. Haematologica 2003;88:845-852.
6. Lee OK, Kuo TK, Chen WM, Lee KD, Hsieh SL, Chen TH: Isolation of multipotent mesenchymal stem cells from umbilical cord blood. Blood 2004;1035:1669-1675.
7. Lu LL, Liu YJ, Yang SG, Zhao QJ, Wang x, Gong W, Han ZB, Xu ZS, Lu YX, Liu D, Chen ZZ, Han ZC: Isolation and characterization ofhuman umbilical cord mesenchymal stem cells with hematopoiesis-supportive function and other potentials. Haematologica 2006;918:1017-1026.
8. Castro-Malaspina H, Gay RE, Resnick G, Kapoor N, Meyers R Chiarieri D, McKenzie S, Broxmeyer HE, Moore MA: Characterization ofhuman bone marrow fibroblast colony-forming cells (CFU-F) and their progeny. Blood 1980;562:289-301.
9. Lazarus HM, Haynesworth SE, Gerson SL, Rosenthal NS, Caplan AI: Ex vivo expansion and subsequent infusion ofhuman bone marrow-derived stromal progenitor cells (mesenchymal progenitor cells): implications fortherapeutic use. Bone Marrow Transplant 1995;164:557-564.
10. Reyes M, Verfaillie CM: Characterization of multipotent adult progenitor cells, a subpopulation of mesenchymal stem cells. Annals N Y Acad Sci 2001;938:231-235.
11. Wang HW, Lin LM, He HY, You F, Li WZ, Huang TH, Ma GX, Ma L: Human umbilical cord mesenchymal stem cells derived from Wharton's jelly differentiate into insulin-producing cells in vitro. Chin Med J (Engl] 2011;12410:1534-1539.
12. Aggarwal S, Pittenger MF. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 2005;1054:1815-1822.
13. Zappia E, Casazza S, Pedemonte E, Benvenuto F, Bonanni I, Gerdoni E, Giunti D, Ceravolo A, Cazzanti F, Frassoni F: Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy. Blood 2005;1065:1755-1761.
14. MacFarlane RJ, Graham SM, Davies PS, Korres N, Tsouchnica H, Heliotis M, Mantalaris A, Tsiridis E: Antiinflammatory role and immunomodulation of mesenchymal stem cells in systemic joint diseases: potential for treatment. Expert Opin Ther Targets 2013;173:243-254.
15. Molendijk I, Duijvestein M, van der Meulen-de Jong AE, van Deen WK, Swets M, Hommes DW, Verspaget HW: Immunomodulatory effects of mesenchymal stromal cells in Crohn's disease. J Allergy(Cairo] 2012;2012:187408.
16. Kim SJ, Diamond B: Generation and maturation ofbone marrow-derived DCs under serum-free conditions. J Immunol Methods 2007;3232:101-108.
17. Ben Azouna N, Jenhani F, Regaya Z, Berraeis L, Ben Othman T, Ducrocq E, Domenech J: Phenotypical and functional characteristics of mesenchymal stem cells from bone marrow: comparison of culture using different media supplemented with human platelet lysate or fetal bovine serum. Stem Cell Res Ther 2012;31:6.
18. Chase LG, Lakshmipathy U, Solchaga LA, Rao MS, Vemuri MC: A novel serum-free medium for the expansion of human mesenchymal stem cells. Stem Cell Res Ther 2010;11:8.
19. Zuo XR, Wang Q, Cao Q, Yu YZ, Wang H, Bi LQ, Xie WP, Wang H: Nicorandil prevents right ventricular remodeling by inhibiting apoptosis and lowering pressure overload in rats with pulmonary arterial hypertension. PloS One 2012;79:e44485.
20. Gao H, Chen C, Huang S, Li B: Quercetin attenuates the progression of monocrotaline-induced pulmonary hypertension in rats.J Biomed Res 2012;262:98-102.
21. Wang D, Chen K, Du WT, Han ZB, Ren H, Chi Y, Yang SG, Bayard F, Zhu D, Han ZC: CD14+ monocytes promote the immunosuppressive effect of human umbilical cord matrix stem cells. Exp Cell Res 2010;31615:2414-2423.
22. Glennie S, Soeiro I, Dyson PJ, Lam EW, Dazzi F: Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells. Blood 2005;1057:2821-2827.
23. Corcione A, Benvenuto F, Ferretti E, Giunti D, Cappiello V, Cazzanti F, Risso M, Gualandi F, Mancardi GL, Pistoia V: Human mesenchymal stem cells modulate B-cell functions. Blood 2006;1071:367-372.
24. Spaggiari GM, Capobianco A, Becchetti S, Mingari MC, Moretta L: Mesenchymal stem cell-natural killer cell interactions: evidence that activated NK cells are capable ofkilling MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation. Blood 2006;1074:1484-1490.
25. Dokic J, Tomic S, Markovic M, Milosavljevic P, Colic M: Mesenchymal stem cells from periapical lesions modulate differentiation and functional properties of monocyte-derived dendritic cells. Eur J Immunol 2013;437:1862-1872.
26. Duffy MM, Ritter T, Ceredig R, Griffin MD: Mesenchymal stem cell effects on T-cell effector pathways. Stem Cell Res Ther 2011;24:34.
27. Duffy MM, Pindjakova J, Hanley SA, McCarthy C, Weidhofer GA, Sweeney EM, English K, Shaw G, Murphy JM, Barry FP: Mesenchymal stem cell inhibition of T-helper 17 cell differentiation is triggered by cell-cell contact and mediated by prostaglandin E2 via the EP4 receptor. Eur J Immunol 2011;4110:2840-2851.
28. Ji YR, Yang ZX, Han ZB, Meng L, Liang L, Feng XM, Yang SG, Chi Y, Chen DD, Wang YW: Mesenchymal stem cells support proliferation and terminal differentiation of B cells. Cell Physiol Biochem 2012;306:1526-1537.
29. Chen K, Wang D, Du WT, Han ZB, Ren H, Chi Y, Yang SG, Zhu D, Bayard F, Han ZC: Human umbilical cord mesenchymal stem cells hUC-MSCs exert immunosuppressive activities through a PGE2-dependent mechanism. Clin Immunol 2010;1353:448-458.
30. Opitz CA, Litzenburger UM, Lutz C, Lanz TV, Tritschler I, Koppel A, Tolosa E, Hoberg M, Anderl J, Aicher WK: Toll-like receptor engagement enhances the immunosuppressive properties of human bone marrow-derived mesenchymal stem cells by inducing indoleamine-2,3-dioxygenase-l via interferon-beta and protein kinase R. Stem Cells 2009;274:909-919.
31. Nemeth K, Keane-Myers A, Brown JM, Metcalfe DD, Gorham JD, Bundoc VG, Hodges MG, Jelinek I, Madala S, Karpati S: Bone marrow stromal cells use TGF-beta to suppress allergic responses in a mouse model of ragweed-induced asthma. Proc Natl Acad Sci USA 2010;10712:5652-5657.
32. Di Nicola M, Carlo-Stella C, Magni M, Milanesi M, Longoni PD, Matteucci P, Grisanti S, Gianni AM: Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 2002;9910:3838-3843.
33. Nauta AJ, Kruisselbrink AB, Lurvink E, Willemze R, Fibbe WE: Mesenchymal stem cells inhibit generation and function ofboth CD34+-derived and monocyte-derived dendritic cells. J Immunol 2006;1774:2080-2087.
34. Selmani Z, Naji A, Gaiffe E, Obert L, Tiberghien P, Rouas-Freiss N, Carosella ED, Deschaseaux F: HLA-G is a crucial immunosuppressive molecule secreted byadulthuman mesenchymal stem cells. Transplantation 2009;879:S62-66.
35. Liu WH, Liu JJ, Wu J, Zhang LL, Liu F, Yin L, Zhang MM, Yu B: Novel mechanism of inhibition of dendritic cells maturation by mesenchymal stem cells via interleukin-10 and the JAK1/STAT3 signaling pathway. PloSOne2013;81:e55487.
36. Whiteside TL, Mandapathil M, Schuler P: The role of the adenosinergic pathway in immunosuppression mediated byhuman regulatory T cells (Treg). Curr Med Chem 2011;1834:5217-5223.
37. Kalinski P: Regulation of immune responses byprostaglandin E2. J Immunol 2012;1881:21-28.
38. Crapnell K, Blaesius R, Hastings A, Lennon DP, Caplan AI, Bruder SP: Growth, differentiation capacity and function of mesenchymal stem cells expanded in serum-free medium developed via combinatorial screening. Exp Cell Res 2013;31910:1409-1418.
39. Ahn B, Empinado HM, Al-Rajhi M, Judge AR, Ferreira LF: Diaphragm atrophy and contractile dysfunction in a murine model of pulmonary hypertension. PloS One 2013;84:e62702.
40. Wang Q, Zuo XR, Wang YY, Xie WP, Wang H, Zhang M: Monocrotaline-induced pulmonary arterial hypertension is attenuated by TNF-alpha antagonists via the suppression of TNF-alpha expression and NF-kappaB pathway in rats. Vascul Pharmacol 2013;58:71-77.
41. Megalou AJ, Glava C, Vilaeti AD, Oikonomidis DL, Baltogiannis GG, Papalois A, Vlahos AP, Kolettis TM: Transforming growth factor-beta inhibition and endothelin receptor blockade in rats with monocrotaline-induced pulmonary hypertension. Pulm Circ 2012; 24: 461-469.
42. Zhang ZH, Lu Y, Luan Y, Zhao JJ: Effect of bone marrow mesenchymal stem cells on experimental pulmonary arterial hypertension. Exp Therap Med 2012;45:839-843.